trending Market Intelligence /marketintelligence/en/news-insights/trending/qZ_PlCrKUY992mH11Sgp8g2 content esgSubNav
In This List

Pluristem upsizes bought-deal financing to $15M

Blog

Insight Weekly: Ukraine war impact on mining; US bank growth slowdown; cloud computing headwinds

Blog

Insight Weekly: Cryptocurrency's growth; green bond market outlook; coal investors' windfall

Blog

Global M&A By the Numbers: Q1 2022

Blog

Insight Weekly: Challenges for European banks; Japan's IPO slowdown; carmakers' supply woes


Pluristem upsizes bought-deal financing to $15M

Pluristem Therapeutics Inc. upsized a previously announced bought-deal offering by $5 million.

The company plans to issue 12,244,898 shares at $1.225 apiece to H.C. Wainwright & Co. LLC for gross proceeds of $15 million, complete with warrants for another 7,346,939 shares.

The warrants are exercisable at $1.40 apiece. The issue is expected to close on or about Jan. 25 and will help the company raise funds for continued research and development, among other things.

Wainwright can purchase a further 1,836,735 shares and 1,102,041 warrants under an overallotment option, which, if exercised in full, will net Pluristem $17.3 million in gross proceeds.

Pluristem was previously offering 8,163,265 shares that were bundled with warrants for an additional 4,897,959 stock. The original issue would have generated $10 million for the company.